Comments Regarding Reauthorization of the Over-the-Counter Monograph Drug User Fee Program Share page: Docket Number: FDA-2023-N-3575-0001 Download Document Issues: OTC Medicines Monograph Reform User Fees Related Posts Timeline for an FDA Order to Determine a Drug is Not GRAS/E Oct 20, 2023 Press Releases and Statements CHPA SVP of Regulatory & Scientific Affairs Delivers Remarks at FDA OMUFA Public Meeting Sep 28, 2023 Press Releases and Statements Citizen Petition Urges FTC to Immediately Withdraw Notice of Penalty Offenses Sent to Hundreds of Consumer Healthcare Companies Sep 15, 2023